Sharon E. Heath

50.7k total citations
14 papers, 357 citations indexed

About

Sharon E. Heath is a scholar working on Hematology, Molecular Biology and Cancer Research. According to data from OpenAlex, Sharon E. Heath has authored 14 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 6 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in Sharon E. Heath's work include Acute Myeloid Leukemia Research (12 papers), Epigenetics and DNA Methylation (5 papers) and Cancer Genomics and Diagnostics (4 papers). Sharon E. Heath is often cited by papers focused on Acute Myeloid Leukemia Research (12 papers), Epigenetics and DNA Methylation (5 papers) and Cancer Genomics and Diagnostics (4 papers). Sharon E. Heath collaborates with scholars based in United States, China and Japan. Sharon E. Heath's co-authors include Timothy J. Ley, Robert S. Fulton, Matthew J. Walter, Daniel C. Link, John F. DiPersio, Nichole Helton, Peter Westervelt, John S. Welch, Richard K. Wilson and Catrina C. Fronick and has published in prestigious journals such as Cell, Nature Communications and Blood.

In The Last Decade

Sharon E. Heath

14 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sharon E. Heath United States	8	237	233	86	49	41	14	357
A Dufour Germany	6	149 0.6×	212 0.9×	56 0.7×	81 1.7×	59 1.4×	6	295
Matthew Ndonwi United States	9	318 1.3×	242 1.0×	57 0.7×	109 2.2×	30 0.7×	11	486
Maja Rothenberg‐Thurley Germany	10	205 0.9×	347 1.5×	92 1.1×	111 2.3×	61 1.5×	27	423
E. S. J. M. de Bont Netherlands	8	148 0.6×	184 0.8×	45 0.5×	30 0.6×	72 1.8×	13	287
Zinia J. Kwidama Netherlands	10	138 0.6×	230 1.0×	47 0.5×	50 1.0×	60 1.5×	13	297
Sue Naim United States	5	233 1.0×	134 0.6×	37 0.4×	27 0.6×	29 0.7×	8	299
Juergen Krauter Germany	7	213 0.9×	332 1.4×	52 0.6×	90 1.8×	69 1.7×	20	424
Federica Cattina Italy	9	136 0.6×	187 0.8×	44 0.5×	80 1.6×	51 1.2×	35	282
Matthew Smith United Kingdom	4	162 0.7×	222 1.0×	47 0.5×	90 1.8×	52 1.3×	8	306
Olaf Hopfer Germany	8	174 0.7×	118 0.5×	35 0.4×	43 0.9×	38 0.9×	15	281

Countries citing papers authored by Sharon E. Heath

Since Specialization

Citations

This map shows the geographic impact of Sharon E. Heath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon E. Heath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon E. Heath more than expected).

Fields of papers citing papers by Sharon E. Heath

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon E. Heath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon E. Heath. The network helps show where Sharon E. Heath may publish in the future.

Co-authorship network of co-authors of Sharon E. Heath

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon E. Heath. A scholar is included among the top collaborators of Sharon E. Heath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon E. Heath. Sharon E. Heath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Abel, Haley, Karolyn A. Oetjen, Christopher A. Miller, et al.. (2023). Genomic landscape of TP53-mutated myeloid malignancies. Blood Advances. 7(16). 4586–4598. 15 indexed citations

Chen, David Y., Sai Mukund Ramakrishnan, Eric J. Duncavage, et al.. (2023). Melanoma in a patient with DNMT3A overgrowth syndrome. Molecular Case Studies. 9(2). a006267–a006267. 3 indexed citations

Abel, Haley, Karolyn A. Oetjen, Christopher A. Miller, et al.. (2023). Genomic landscape of TP53-mutated myeloid malignancies. Zenodo (CERN European Organization for Nuclear Research). 1 indexed citations

Yao, Juo-Chin, Karolyn A. Oetjen, Jun Xia, et al.. (2022). IL-1β expression in bone marrow dendritic cells is induced by TLR2 agonists and regulates HSC function. Blood. 140(14). 1607–1620. 16 indexed citations

Helton, Nichole, Sharon E. Heath, Robert S. Fulton, et al.. (2021). Focal disruption of DNA methylation dynamics at enhancers in IDH-mutant AML cells. Leukemia. 36(4). 935–945. 19 indexed citations

Smith, Amanda M., Marwan Shinawi, Sai Mukund Ramakrishnan, et al.. (2021). Functional and epigenetic phenotypes of humans and mice with DNMT3A Overgrowth Syndrome. Nature Communications. 12(1). 4549–4549. 32 indexed citations

Jacoby, Meagan A., Eric J. Duncavage, Gue Su Chang, et al.. (2018). Subclones dominate at MDS progression following allogeneic hematopoietic cell transplant. JCI Insight. 3(5). 36 indexed citations

Jacoby, Meagan A., Eric J. Duncavage, Christopher A. Miller, et al.. (2018). Exome analysis of treatment‐related AML after APL suggests secondary evolution. British Journal of Haematology. 185(5). 984–987. 1 indexed citations

Spencer, David H., David A. Russler‐Germain, Shamika Ketkar, et al.. (2017). CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML Progression. Cell. 168(5). 801–816.e13. 149 indexed citations

10.

Petti, Allegra A., Christopher Miller, Lukas D. Wartman, et al.. (2016). Clonal Evolution of Acute Myeloid Leukemia Following Allogeneic Stem Cell Transplantation. Blood. 128(22). 1528–1528. 1 indexed citations

11.

Wong, Terrence N., Christopher A. Miller, Jeffery M. Klco, et al.. (2015). Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AML. Blood. 127(7). 893–897. 72 indexed citations

12.

Uy, Geoffrey L., Eric J. Duncavage, Gue Su Chang, et al.. (2015). Dynamic Changes in the Clonal Structure of MDS and AML in Response to Epigenetic Therapy. Blood. 126(23). 610–610. 2 indexed citations

13.

Wong, Terrence N., Giridharan Ramsingh, Andrew L. Young, et al.. (2013). The Role Of Early TP53 Mutations On The Evolution Of Therapy-Related AML. Blood. 122(21). 5–5. 9 indexed citations

14.

Ramsingh, Giridharan, Dong Shen, Tamara Lamprecht, et al.. (2012). Whole Genome Sequencing of Therapy-Related Acute Myeloid Leukemia. Blood. 120(21). 784–784. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact